Yh. Cao et al., KRINGLE DOMAINS OF HUMAN ANGIOSTATIN - CHARACTERIZATION OF THE ANTIPROLIFERATIVE ACTIVITY ON ENDOTHELIAL-CELLS, The Journal of biological chemistry, 271(46), 1996, pp. 29461-29467
Recently we have identified angiostatin, an endogenous angiogenesis in
hibitor of 38 kDa which specifically blocks the growth of endothelial
cells (O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal,
R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (
1994) Cell 79, 315-328; Folkman, J. (1995) Nat. Med. 1, 27-31). Angios
tatin was shown to represent an internal fragment of plasminogen conta
ining the first four kringle structures. We now report on the inhibito
ry effects of individual or combined kringle structures of angiostatin
on capillary endothelial cell proliferation. Recombinant kringle 1 an
d kringle 3 exhibit potent inhibitory activity with half-maximal conce
ntrations (ED(50)) of 320 nM and 460 nM, respectively. Also, recombina
nt kringle 2 displays a significant inhibition, although decreased com
pared with both kringle 1 and kringle 3. In contrast, kringle 4 is an
ineffective inhibitor of basic fibroblast growth factor-stimulated end
othelial cell proliferation. Among the tandem kringle arrays, the reco
mbinant kringle 2-3 fragment exerts inhibitory activity similar to kri
ngle 2 alone. However, relative to kringle 2-3, a marked enhancement i
n inhibition is observed when individual kringle 2 and kringle 3 are a
dded together to endothelial cells. This implies that it is necessary
to open the cystine bridge between kringle 2 and kringle 3 to obtain t
he maximal inhibitory effect of kringle 2-3. An increased (<2-fold) in
hibitory activity is observed for the kringle 1-3 fragment (ED(50) = 7
0 nM) compared with kringle 1-4 (ED(50) = 135 nn). These data indicate
that the anti-proliferative activity of angiostatin on endothelial ce
lls is shared by kringle 1, kringle 2, and kringle 3, but probably not
by kringle 4 and that more potent inhibition results when kringle 4 i
s removed from angiostatin. Thus, in view of the variable lysine affin
ity of the homologous domains, it would appear that lysine binding cap
ability does not correlate with the relative inhibitory effects of the
kringle-containing constructs. However, as we also demonstrate, appro
priate folding of kringle structures is essential for angiostatin to m
aintain its full anti-endothelial activity.